Literature DB >> 10596716

Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.

C E Brightling1, G Woltmann, A J Wardlaw, I D Pavord.   

Abstract

Eosinophilic bronchitis is a recently described condition presenting with chronic cough and sputum eosinophilia without the abnormalities of airway function seen in asthma. The patient, a 48-yr-old male who had never smoked, presented with an isolated chronic cough. He had normal spirometric values, peak flow variability and airway responsiveness, but an induced sputum eosinophil count of 33% (normal <1%). Although his cough improved with inhaled corticosteroids the sputum eosinophilia persisted. Over 2 yrs he developed airflow obstruction, which did not improve following nebulized bronchodilators and a 2-week course of prednisolone 30 mg once daily sufficient to return the sputum eosinophilia to normal (0.5%). It is suggested that the progressive irreversible airflow obstruction was due to persistent structural change to the airway secondary to eosinophilic airway inflammation, and it is further speculated that eosinophilic bronchitis may be a prelude to chronic obstructive pulmonary disease in some patients.

Entities:  

Mesh:

Year:  1999        PMID: 10596716     DOI: 10.1183/09031936.99.14512289

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

Review 1.  Non-astmatic Eosinophilic Bronchitis.

Authors:  Tekin Yıldız; Seyhan Dülger
Journal:  Turk Thorac J       Date:  2017-09-27

Review 2.  Eosinophilic bronchitis: clinical manifestations and implications for treatment.

Authors:  P G Gibson; M Fujimura; A Niimi
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

Review 3.  Cough due to asthma and nonasthmatic eosinophilic bronchitis.

Authors:  Christopher E Brightling
Journal:  Lung       Date:  2009-08-08       Impact factor: 2.584

Review 4.  Are We Meeting the Promise of Endotypes and Precision Medicine in Asthma?

Authors:  Anuradha Ray; Matthew Camiolo; Anne Fitzpatrick; Marc Gauthier; Sally E Wenzel
Journal:  Physiol Rev       Date:  2020-01-09       Impact factor: 37.312

5.  Eosinophil-derived IL-13 promotes emphysema.

Authors:  Alfred D Doyle; Manali Mukherjee; William E LeSuer; Tyler B Bittner; Saif M Pasha; Justin J Frere; Joseph L Neely; Jake A Kloeber; Kelly P Shim; Sergei I Ochkur; Terence Ho; Sarah Svenningsen; Benjamin L Wright; Matthew A Rank; James J Lee; Parameswaran Nair; Elizabeth A Jacobsen
Journal:  Eur Respir J       Date:  2019-05-30       Impact factor: 16.671

6.  Unusual asthma syndromes and their management.

Authors:  Jaymin B Morjaria; Jack A Kastelik
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

7.  Comparison of airway immunopathology of eosinophilic bronchitis and asthma.

Authors:  C E Brightling; F A Symon; S S Birring; P Bradding; A J Wardlaw; I D Pavord
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

8.  Eosinophilic bronchitis-like lesion as the cause of death in a Macaca mulatta: a first case report.

Authors:  J L Christal; G B Hubbard; E J Dick; K M Brasky; J Jagirdar
Journal:  J Med Primatol       Date:  2008-04       Impact factor: 0.667

9.  Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens.

Authors:  Neerad C Mishra; Jules Rir-Sima-Ah; Raymond J Langley; Shashi P Singh; Juan C Peña-Philippides; Takeshi Koga; Seddigheh Razani-Boroujerdi; Julie Hutt; Matthew Campen; K Chul Kim; Yohannes Tesfaigzi; Mohan L Sopori
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 10.  Cough. 4: Cough in asthma and eosinophilic bronchitis.

Authors:  P V Dicpinigaitis
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.